EZH2 in Bladder Cancer, a Promising Therapeutic Target

By Martínez-Fernández Mónica   Rubio Carolina   Segovia Cristina   López-Calderón Fernando F.   Dueñas Marta   Paramio Jesús M.  

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 27107-27132

MDPI

Access to resources Recommend Favorite

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

By Chua Melissa M.J.   Ortega Charina E.   Sheikh Ayesha   Lee Migi   Abdul-Rassoul Hussein   Hartshorn Kevan L.   Dominguez Isabel  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

The Crosstalk between Nrf2 and Inflammasomes

By Hennig Paulina   Garstkiewicz Martha   Grossi Serena   Di Filippo Michela   French Lars E.   Beer Hans-Dietmar  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 562-562

MDPI

Access to resources Recommend Favorite

Nrf2 and Redox Status in Prediabetic and Diabetic Patients

By Jiménez-Osorio Angélica S.   Picazo Alejandra   González-Reyes Susana   Barrera-Oviedo Diana   Rodríguez-Arellano Martha E.   Pedraza-Chaverri José  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 20290-20305

MDPI

Access to resources Recommend Favorite

Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer

By Aruleba Raphael Taiwo   Adekiya Tayo Alex   Oyinloye Babatunji Emmanuel   Kappo Abidemi Paul  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 386-386

MDPI

Access to resources Recommend Favorite